“Vice President Harris Urged to Address Patent Thickets in Effort to Curb Drug Prices”

In addressing high drug prices, Vice President Kamala Harris must confront the issue of patent thickets, according to Tahir Amin at the Initiative for Medicines, Access & Knowledge. Patent thickets refer to the extensive and overlapping patent rights that pharmaceutical companies use to deter competition from generic or biosimilar companies. Harris’s previous statements on utilizing march-in rights highlight her commitment to tackling such issues. This move is crucial, especially in the context of her recent nomination for president and her partnership with President Joe Biden in negotiating lower drug prices through Medicare. More details on the significance of this approach can be found in the original article [here](https://www.law360.com/articles/1876123/to-lower-drug-prices-harris-must-address-patent-thickets).